TRIO Study (Tablets, Rings, and Injectables as Options for women)

Principal Investigator(s):
Objective:Seeks to evaluate the acceptability of three multipurpose, prevention technologies (MPTs) as delivery forms for HIV prevention and unintended pregnancy among young women in Kenya. The three MPTs include, tablet, Ring and Injection.
Prevention Option(s):Microbicides, MPTs
Study Design:
Official Code: TRIO Study
Trial Sponsors: Bill & Melinda Gates Foundation
Start Date
End Date
November 15, 2014
May 15, 2016
Age range: 18 Years ↔ 30 Years
Population:Cisgender Women